IPCA LABORATORIES
|
The Current P/S Ratio of IPCA LABORATORIES is 4.52.
| Share Price | ₹1,718.4 | Jul 02,2026 |
| Market Cap | ₹43,595.8 Cr | |
| Sales-TTM | ₹9,646.3 Cr | TTM-Consolidated Results |
| Price/Sales | 4.52x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of IPCA LABORATORIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹43,595.8 Cr] as on Jul 02,2026
(/) Sales [ ₹9,646.3 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 4.52x ]
Thus, for IPCA LABORATORIES , the investors are currently willing to pay '4.52 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of IPCA LABORATORIES !
The chart below summarizes the trend in P/S Ratio of IPCA LABORATORIES over the last five years.
Historical PS (Price/Sales) ratio chart of IPCA LABORATORIES
PS Ratio Performance Analysis for IPCA LABORATORIES
- IPCA LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 4.16x.
- IPCA LABORATORIES 's operated at median p/e ratio of 4.28x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, IPCA LABORATORIES 's p/e ratio peaked in Mar2022 at 4.64x.
- IPCA LABORATORIES 's p/e ratio hit its five-year low in Mar2023 of 3.31x.
How does IPCA LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| IPCA LABORATORIES | 9,646.3 | 4.52 | 43,595.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 58,462.0 | 7.68 | 449,048.0 |
| DIVIS LABORATORIES LTD | 10,560.0 | 16.78 | 177,179.0 |
| TORRENT PHARMACEUTICALS LTD | 13,980.0 | 11.29 | 157,804.0 |
| CIPLA LTD | 28,162.6 | 4.18 | 117,642.0 |
| DR REDDYS LABORATORIES LTD | 33,700.2 | 3.33 | 112,368.0 |
| MANKIND PHARMA LTD | 14,277.6 | 7.20 | 102,729.0 |
| LUPIN LTD | 27,958.0 | 3.92 | 109,676.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 4.04 | 109,691.0 |
| AUROBINDO PHARMA LTD | 33,653.1 | 2.67 | 89,761.8 |
| LAURUS LABS LTD | 6,812.9 | 12.09 | 82,398.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs IPCA LABORATORIES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.67x |
| Max industry PS | 16.78x |
| Median industry PS | 4.52x |
| Average industry PS | 7.06x |
You may also like the below Video Courses